This is a great webinar, thanks for sharing. Clearly there is a major issue globally about how to classify and treat cannabis from a regulatory perspective, the case Tamir spoke of with regards to the efficacy of cannabis vs opiates for a terminal patient that gave him 5 weeks of pain relief without the stultifying effects of opiates is proof in action - and in support of Tommy Huppert's comments, we need the testing and data to underpin this clear evidence. With strong research and data, I am confident that long term we will view the legalisation of cannabis (both medicinal and recreational) as a logical step and companies such as IHL whom will contribute to this research, will not just profit and grow but genuinely provide improved patient outcomes. It therefore becomes a moral imperative to support the efforts of IHL to my mind. All in MYHO only - good luck to all.
Cheers Hoffy
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-3550
-
- There are more pages in this discussion • 16,347 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online